Not recognizing a patient’s self-identity can create communication barriers that clinicians may not even realize exist. Barbara Snyder, MD, will kick off a special symposium on gender and sexuality issues in medicine.

Activity disruption — doing things differently or not at all — is an important indicator of disease status, according to Catherine L. Backman, PhD, who will deliver this year’s ARHP Distinguished Lecture.

Ingrid Möller, MD, PhD, will describe relevant structures in the anterior hip that may generate pain during a Sunday morning symposium that’s part of the new series of “Anatomy for the Clinician.”

Multiple labs have uncovered regulatory B cells, with the subset that secretes IL-10, dubbed B10 cells by the lab led by Thomas F. Tedder, PhD.

When Arthur Weiss, MD, PhD, began investigating T cells in the 1980s, the mechanisms by which they functioned and malfunctioned were little more than a black box. The only thing that was clear was that something interacted with cells to affect genes that had something to do with growth factors, cytokines, and lymphokines to produce…

Daniel F. Battafarano, DO, MACP, FACR, said that 50 percent of rheumatologists are Baby Boomers and likely to retire over the next 15 years.

To get the most out of the Annual Meeting experience, all attendees are invited to attend the ACR/ARHP Annual Meeting Orientation session on Sunday. The session will be led by William St.Clair, MD, ACR Past President, and Kamala Nola, PharmD, MS, ARHP Past President.

“Osteoarthritis is by far the most common form of arthritis and has gotten much less attention than many of the other more obviously inflammatory forms,” said Frank Beier, PhD.

Johnny Huard, PhD, will discuss the evidence supporting cell-based therapies for joint tissue repair, as well as current stem cell applications in the treatment of arthritis.